Approach to the patient: management of bone fragility in patients with chronic hypoparathyroidism
The Journal of Clinical Endocrinology & Metabolism · 2026
DOI: 10.1210/clinem/dgag160 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, 2026. Verfasst von Symeon Tournis und 7 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory for Research of the Musculoskeletal System "Th. Garofalidis", Medical School, National and Kapodistrian University of Athens, KAT Hospital…. Hauptthemen laut MEDLINE: Hypoparathyroidism, Bone Density Conservation Agents, Osteoporosis, Fractures, Bone. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 132 Literaturangaben.
Abstract (Originalsprache)
Parathyroid hormone is the main hormonal regulator of bone remodeling; thus, chronic hypoparathyroidism (HypoPT) leads to low bone turnover that might compromise bone strength, despite the normal or even high bone mineral density. Recent studies suggest that fracture risk might be increased in patients with HypoPT. Given that all available treatments for osteoporosis affect bone remodeling, management of bone fragility of any etiology in patients with HypoPT is challenging and lacks clinical evidence in terms of fracture risk reduction. In the present article, we describe the changes in bone remodeling and bone strength in patients with chronic HypoPT managed by conventional therapy and under PTH replacement. In addition, based on pathophysiology and the limited existing evidence, we discuss which osteoporosis medication could be used in patients with HypoPT and concurrent increased bone fragility. In HypoPT patients under conventional treatment with calcium and active vitamin D, administration of potent antiresorptives (bisphosphonates, denosumab) should be done under close monitoring, given their antiremodeling action that might result in hypocalcemia; the effect on bone material properties is not known. Teriparatide is probably the best available option, at least in the short term. In contrast, patients with HypoPT on long-term PTH replacement therapy who experience fragility fractures should probably be treated with antiresorptives, although the optimal therapeutic regimen, in terms of safety and efficacy, is yet unknown.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory for Research of the Musculoskeletal System "Th. Garofalidis", Medical School, National and Kapodistrian University of Athens, KAT Hospital, Athens 14561, Greece.
- Centre of Expertise in Rare Endocrine Diseases, C.E.R.E.D -Disorders of Calcium and Phosphate Metabolism, Endocrinology Unit, 1st Department of Propaedeutic Internal Medicine, LAIKO General Hospital of Athens, National…
- Unit of Metabolic Bone and Thyroid Disorders, Fondazione Policlinico Universitario Campus Bio-Medico, Rome 00128, Italy.
- Department of Endocrinology and Diabetes, Hippokratio General Hospital, Thessaloniki 54642, Greece.
- 3rd Department of Internal Medicine, "Papageorgiou" General Hospital, Aristotle University of Thessaloniki, Thessaloniki 56403, Greece.
- Department of Endocrinology and Diabetes and Department of Medical Research, 251 Hellenic Air Force General Hospital, Athens 11525, Greece.
ORCID-Profile: Symeon Tournis, Andrea Palermo, Athanasios D Anastasilakis
Zitieren
APA
Tournis, S., Kassi, E., Palermo, A., Yavropoulou, M. P., Adamidou, F., Anagnostis, P., Makras, P., & Anastasilakis, A. D. (2026). Approach to the patient: management of bone fragility in patients with chronic hypoparathyroidism. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/clinem/dgag160
Vancouver
Tournis S, Kassi E, Palermo A, Yavropoulou MP, Adamidou F, Anagnostis P, et al. Approach to the patient: management of bone fragility in patients with chronic hypoparathyroidism. The Journal of Clinical Endocrinology & Metabolism. 2026. doi:10.1210/clinem/dgag160
BibTeX
@article{Tournis2026,
author = {Tournis, Symeon and Kassi, Evanthia and Palermo, Andrea and Yavropoulou, Maria P and Adamidou, Fotini and Anagnostis, Panagiotis and Makras, Polyzois and Anastasilakis, Athanasios D},
title = {Approach to the patient: management of bone fragility in patients with chronic hypoparathyroidism},
journal = {The Journal of Clinical Endocrinology & Metabolism},
year = {2026},
doi = {10.1210/clinem/dgag160}
}
EUVIMED